Update of evidence in chemotherapy for breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s10147-007-0719-1.pdf
Reference29 articles.
1. Goldhirsch A, Wood W, Gelber R, et al. (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133–1144
2. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717
3. Berry DA, Cirrincione C, Henderson IC, et al. (2006) Estrogen receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295:1658–1662
4. Pritchard KI, Shepherd LE, O’Malley FP, et al.; National Cancer Institute of Canada Clinical Trials Group (2006) HER2 and responsiveness of breast cancer to adjuvant chemotherapy. N Engl J Med 354:2103–2111
5. Paik S, Bryant J, Tan-Chiu E, et al. (2000) HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15. J Natl Cancer Inst 92:1991–1998
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer;Tumors of female reproductive system;2021-01-12
2. microRNA-210 as a prognostic factor in patients with breast cancer: Meta-analysis;Cancer Biomarkers;2013-12-27
3. Prognostic role of caveolin in breast cancer: A meta-analysis;The Breast;2013-08
4. c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer;British Journal of Surgery;2013-01-14
5. iTRAQ-Based Proteomic Profiling of Breast Cancer Cell Response to Doxorubicin and TRAIL;Journal of Proteome Research;2012-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3